Table 2.
Survival rate of the two groups during 12 months follow-up.
| Discharge | 1 m | 2 m | 6 m | 12 m | |
|---|---|---|---|---|---|
| IABP group (n = 29) | 19 (69.57%) | 18 (60.87%) | 18 (60.87%) | 18 (60.87%) | 17 (47.83%) |
| ECMO&IABP group (n = 10) | 9 (90%) | 9 (90%) | 9 (90%) | 9 (90%) | 9 (90%) |
Survival rate of the two groups during 12 months follow-up.
| Discharge | 1 m | 2 m | 6 m | 12 m | |
|---|---|---|---|---|---|
| IABP group (n = 29) | 19 (69.57%) | 18 (60.87%) | 18 (60.87%) | 18 (60.87%) | 17 (47.83%) |
| ECMO&IABP group (n = 10) | 9 (90%) | 9 (90%) | 9 (90%) | 9 (90%) | 9 (90%) |